PD
IMVT icon

Point72 (DIFC)’s Immunovant IMVT Stock Holding History

Point72 (DIFC)’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$446K Buy
+27,698
New +$448K 0.03% 297
2025
Q2 		– Sell
-3,923
Closed -$67K – 1828
2025
Q1 		$67K Buy
+3,923
New +$82.1K ﹤0.01% 1151

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Point72 (DIFC)'s IMVT Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Immunovant (IMVT) in Q3 2025: 27,698 shares worth $446K. The stake represents 0.03% of the portfolio and ranks #297 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in IMVT as recently as Q1 2025.

Point72 (DIFC) first reported a position in IMVT in Q1 2025 and has held it in 2 quarters since. 186 funds tracked by Wall St. Rank hold IMVT as of Q3 2025.

  • Point72 (DIFC) held 27,698 shares of Immunovant worth $446K as of Q3 2025.
  • Immunovant was a new Point72 (DIFC) position in Q3 2025.
  • Immunovant made up 0.03% of Point72 (DIFC)'s portfolio in Q3 2025, its #297 holding.
  • Point72 (DIFC) first reported a position in Immunovant in Q1 2025 and has held it in 2 quarters since.
  • 186 funds tracked by Wall St. Rank held Immunovant as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.